Cell death biomarkers as early predictors for hepatic dysfunction in patients after orthotopic liver transplantation

Transplantation

Volumn 94, Issue 2, 2012, Pages 185-191

  Brenner, Thorsten ^a   Rosenhagen, Claudia ^a   Brandt, Holger ^a   Schmitt, Felix C F ^a   Jung, Gregor E ^a   Schemmer, Peter ^a   Schmidt, Jan ^a,b   Mieth, Markus ^a   Bruckner, Thomas ^a   Lichtenstern, Christoph ^c   Martin, Eike O ^a   Weigand, Markus A ^c   Hofer, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Hirslanden Hospital   (Switzerland)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cell death biomarkers; Inflammation; Necrosis; Orthotopic liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CYTOKERATIN 18; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PEPTIDE FRAGMENT; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ARTERY OCCLUSION; ARTICLE; BILE DUCT BYPASS; BILE DUCT INJURY; BILIARY TRACT DISEASE; BLOOD SAMPLING; CADAVER DONOR; CELL DEATH; CHOLANGITIS; CONTROLLED STUDY; DISEASE COURSE; HEPATIC ARTERY; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER PERFUSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PNEUMONIA; PORTAL VEIN OBSTRUCTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; THROMBOSIS; URINARY TRACT INFECTION; VIRUS HEPATITIS;

BIOLOGICAL MARKERS; CELL DEATH; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KERATIN-18; LIVER DISEASES; LIVER TRANSPLANTATION; LOGISTIC MODELS; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864277607     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318254397c     Document Type: Article

References (46)

1. Mueller AR, Platz KP, Kremer B. Early postoperative complications following liver transplantation. Best Pract Res Clin Gastroenterol 2004; 18: 881.
2. Schmidt J, Muller SA, Mehrabi A, et al. Orthotopic liver transplantation. Techniques and results [in German]. Chirurg 2008; 79: 112.
3. Hofer S, Brenner T, Bopp C, et al. Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 2009; 13: R93.
4. Volkmann X, Anstaett M, Hadem J, et al. Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 2008; 47: 1624.
5. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45.
6. Weigand MA, Schmidt H, Pourmahmoud M, et al. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 1999; 27: 2656.
7. Avellini C, Baccarani U, Trevisan G, et al. Redox proteomics and immunohistology to study molecular events during ischemiareperfusion in human liver. Transplant Proc 2007; 39: 1755.
8. Picker O, Beck C, Pannen B. Liver protection in the perioperative setting. Best Pract Res Clin Anaesthesiol 2008; 22: 209.
9. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia Yreperfusion injury. Am J Surg 2001; 181: 160.
10. Tanigawa K. Reperfusion injury in liver transplantation. Curr Opin Anaesthesiol 2000; 13: 349.
11. Vascotto C, Cesaratto L, D'Ambrosio C, et al. Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics 2006; 6: 3455.
12. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injuryVa fresh look. Exp Mol Pathol 2003; 74: 86.
13. Schemmer P, Mehrabi A, Kraus T, et al. New aspects on reperfusion injury to liverVimpact of organ harvest. Nephrol Dial Transplant 2004; 19: iv26.
14. Abela CB, Homer-Vanniasinkham S. Clinical implications of ischaemiaYreperfusion injury. Pathophysiology 2003; 9: 229.
15. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000; 7: 153.
16. Tashiro H, Itamoto T, Ohdan H, et al. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factorYrelated apoptosisinducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation. Transpl Int 2004; 17: 626.
17. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant.
18. Jaeschke H, Fisher MA, Lawson JA, et al. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alphaYinduced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998; 160: 3480.
19. Liedtke C, Plumpe J, Kubicka S, et al. Jun kinase modulates tumor necrosis factorYdependent apoptosis in liver cells. Hepatology 2002; 36: 315.
20. Shinozuka H, Kubo Y, Katyal SL, et al. Roles of growth factors and of tumor necrosis factorYalpha on liver cell proliferation induced in rats by lead nitrate. Lab Invest 1994; 71: 35.
21. Webber EM, Bruix J, Pierce RH, et al. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 1998; 28: 1226.
22. Yamada Y, Kirillova I, Peschon JJ, et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997; 94: 1441.
23. Aldrighetti L, Pulitano C, Arru M, et al. Impact of preoperative steroids administration on ischemiaYreperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006; 12: 941.
24. Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996; 224: 647.
25. Kimura F, Shimizu H, Yoshidome H, et al. Circulating cytokines, chemokines, and stress hormones are increased in patients with organ dysfunction following liver resection. J Surg Res 2006; 133: 102.
26. Muratore A, Ribero D, Ferrero A, et al. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 2003; 90: 17.
27. Shimada M, Saitoh A, Kano T, et al. The effect of a perioperative steroid pulse on surgical stress in hepatic resection. Int Surg 1996; 81: 49.
28. Yamashita Y, Shimada M, Hamatsu T, et al. Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg 2001; 136: 328.
29. Liu P, Xu B, Hock CE, et al. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 1998; 275: H2191.
30. Bouazzaoui A, Spacenko E, Mueller G, et al. Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft-vs.-host disease of the intestinal tract. Exp Hematol 2011; 39: 238.
31. Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248: 1042.
32. Schmidt SC, Hamann S, Langrehr JM, et al. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study. J Hepatobiliary Pancreat Surg 2007; 14: 484.
33. Daemen MA, van 't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104: 541.
34. Gujral JS, Bucci TJ, Farhood A, et al. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33: 397.
35. D'Amico F, Vitale A, Gringeri E, et al. Liver transplantation using suboptimal grafts: impact of donor harvesting technique. Liver Transpl 2007; 13: 1444.
36. Ulukaya S, Ulukaya E, Alper I, et al. Soluble cytokeratin 18 biomarkers may provide information on the type of cell death during early ischemia and reperfusion periods of liver transplantation. Clin Transplant 2010; 24: 848.
37. Mueller AR, Platz KP, Krause P, et al. Perioperative factors influencing patient outcome after liver transplantation. Transpl Int 2000; 13: S158.
38. Bantel H, Schulze-Osthoff K. Cell death in sepsis: a matter of how, when, and where. Crit Care 2009; 13: 173.
39. Schwerk C, Schulze-Osthoff K. Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 2003; 66: 1453.
40. Rutherford AE, Hynan LS, Borges CB, et al. Serumapoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol 2007; 5: 1477.
41. Bantel H, Lugering A, Poremba C, et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 2001; 34: 758.
42. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437.
43. Walsh MJ, Vanags DM, Clouston AD, et al. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39: 1230.
44. Schneider L, Latanowicz S, Spiegel M, et al. Prospective validation of a simple laboratory score to predict outcome after orthotopic liver transplantation. Transplant Proc 2011; 43: 1747.
45. Schneider L, Spiegel M, Latanowicz S, et al. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation. Hepatobiliary Pancreat Dis Int 2004; 10: 362.
46. Mieth M, Schemmer P, Encke J, et al. Heidelberger Manual der Lebertransplantation. Heidelberg, Germany: Schmidt J, Sauer P, Büchler MW; 2006.